Hep C Treatment - Biosimilars Shake up the Biologics Market

Biosimilars Shake up the Biologics Market
Genetic Engineering News - Loss of patent protection now leads to a rapid decrease in sales for the innovators' branded small molecule drugs in the U.S. and, to a lesser extent, Europe. Exceptions in the U.S. include new branded indications (three years additional exclusivity

XTL to Lay Off 25 Percent of Work Force
MSN MoneyCentral - NEW YORK (AP) - Drug developer XTL Biopharmaceuticals Ltd. said Friday that it is laying off 25 percent of its work force to focus resources on the development on two

Tight Hepatitis screening cuts entry of affected
MENAFN - DOHA: Stringent screening of incumbent workers bound for GCC states back home has curbed the number of foreigners arriving in Qatar with Hepatitis-B and